Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Conditions: Breast Atypical Hyperplasia; Breast Carcinoma; Breast Ductal Carcinoma In Situ; Breast Lobular Carcinoma In Situ Interventions: Drug: Acolbifene Hydrochloride; Procedure: Biospecimen Collection; Procedure: Mammography; Procedure: Random Periareolar Fine-Needle Aspiration; Drug: Tamoxifen Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Carcinoma | Breast Needle Aspiration | Cancer | Cancer & Oncology | Carcinoma | Fine Needle Aspiration | Mammography | Research | Tamoxifen | Women